ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,618.51
      0.74%
      US Tech 100
      20,090.80
      0.90%
      Dow Jones
      39,547.83
      0.65%
      Brent Oil
      84.965
      0.32%
      Bitcoin
      57,378.94
      -1.10%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cardio Diagnostics Holdings Inc (CDIO) Quote

      Cardio Diagnostics Holdings Inc

      Cardio Diagnostics Holdings Inc (CDIO)

      NASDAQ
      0.5501
      -0.0004
      ( -0.07% )
      Updated: 15:02:30
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.5501
      Bid
      0.5501
      Ask
      0.555
      Volume
      76,112
      0.5411 Day's Range 0.5799
      0.171 52 Week Range 3.56
      Market Cap
      12.488M
      Previous Close
      0.5505
      Open
      0.555
      Last Trade
      1
      @
      0.5501
      Last Trade Time
      15:07:31
      Financial Volume
      $ 42,242
      VWAP
      0.554995
      Average Volume (3m)
      502,397
      Shares Outstanding
      22,685,589
      Dividend Yield
      -
      PE Ratio
      -1.49
      Earnings Per Share (EPS)
      -0.37
      Revenue
      17k
      Net Profit
      -8.38M

      About Cardio Diagnostics Holdings Inc

      Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

      Sector
      In Vitro,in Vivo Diagnostics
      Industry
      In Vitro,in Vivo Diagnostics
      Headquarters
      Dover, Delaware, USA
      Founded
      1970
      Cardio Diagnostics Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was $0.55. Over the last year, Cardio Diagnostics shares have traded in a share price range of $ 0.171 to $ 3.56.

      Cardio Diagnostics currently has 22,685,589 shares outstanding. The market capitalization of Cardio Diagnostics is $12.49 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -1.49.

      CDIO Latest News

      More News

      FeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch

      7 hours ago

      Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

      Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

      June 27 2024
      Business Wire

      Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

      Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at...

      June 27 2024
      Business Wire

      Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

      Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will sponsor a booth and showcase its groundbreaking...

      June 25 2024
      Business Wire

      Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

      Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful completion of its System and Organization Controls (SOC...

      June 10 2024
      Business Wire

      Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

      Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx) program. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

      May 21 2024
      Business Wire

      Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week

      Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood tests, Epi+Gen CHD and PrecisionCHD...

      May 13 2024
      Business Wire

      Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually

      The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD™ Test for the Detection and Management of Coronary Heart Disease, which is One of the Largest Cost...

      April 29 2024
      Business Wire

      Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

      Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in personalized and preventive cardiac...

      April 09 2024
      Business Wire

      Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

      Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an innovative digital health technology...

      April 04 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.01011.870370370370.540.57990.53991483450.55754941CS
      4-0.0499-8.316666666670.60.650.491955070.56780174CS
      12-0.4599-45.53465346531.011.120.495023970.80671305CS
      26-2.3799-81.22525597272.933.180.495524631.45694913CS
      52-0.5499-49.99090909091.13.560.17139751271.30988731CS
      156-3.6999-87.05647058824.258.49990.17129754382.02510117CS
      260-3.6999-87.05647058824.258.49990.17129754382.02510117CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KZIAKazia Therapeutics Ltd
      $ 0.59699
      (210.93%)
      		411.1M
      IVPInspire Veterinary Partners Inc
      $ 7.3301
      (108.24%)
      		19.39M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.0998
      (66.33%)
      		3.1k
      VVPRVivoPower International PLC
      $ 4.1607
      (63.16%)
      		41.36M
      QUREuniQure NV
      $ 10.825
      (62.29%)
      		54.36M
      ZAPPZapp Electric Vehicles Group Ltd
      $ 10.61
      (-40.89%)
      		8.13M
      SISIShineco Inc
      $ 2.75
      (-39.02%)
      		1.43M
      ICUSeaStar Medical Holding Corporation
      $ 8.71
      (-33.00%)
      		976.52k
      CVRXCVRx Inc
      $ 7.845
      (-32.55%)
      		1.25M
      MLGOMicroAlgo Inc
      $ 3.89
      (-29.40%)
      		4.15M
      KZIAKazia Therapeutics Ltd
      $ 0.59699
      (210.93%)
      		411.1M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.206
      (-16.94%)
      		219.93M
      NVDANVIDIA Corporation
      $ 134.3298
      (2.25%)
      		185.77M
      VRPXVirpax Pharmaceuticals Inc
      $ 1.66
      (43.10%)
      		114.44M
      TSLATesla Inc
      $ 264.5199
      (0.83%)
      		110.28M

      CDIO Discussion

      View Posts
      Awl416 Awl416 2 months ago
      Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
      👍️0
      tw0122 tw0122 2 months ago
      Unfortunately dilution so catch it now .54- .58 nice short play
      👍️0
      rosemountbomber rosemountbomber 2 months ago
      I think I am joining your logic. Only a small position here, but think I will unload on any uptick.
      👍️0
      Whalatane Whalatane 2 months ago
      RMB. I think I posted previously that most won't pay for their tests so I was not investing in it.
      Advances in AI are making their tech redundant
      JMO
      Kiwi
      👍️0
      Whalatane Whalatane 2 months ago
      RMB. I don't have a position in CDIO but will chk the news
      Kiwi
      👍️0
      rosemountbomber rosemountbomber 2 months ago
      North, Kiwi, as we all have interest here in CDIO and have also experienced Amarin here is another example of how insurance companies only think of today and saving money. Today CDIO released a study showing their technology identifying CVD could save the insurers 113 million. Yeah I guess some would say it is small potatoes. But the stock not going up on the news, because everyone knows insurers don't give a hoot.
      👍️0
      luckydude777 luckydude777 3 months ago
      Below $.80 excellant value price.
      👍️0
      YankeMike YankeMike 3 months ago
      Looks like it was because of this:

      Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Lowers Price Target to $1.35
      7:47 am ET April 19, 2024 (Benzinga) Print
      Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and lowers the price target from $4 to $1.35.
      👍️0
      rosemountbomber rosemountbomber 3 months ago
      North this along with HSCS has taken a beating. Are they going kaput?
      👍️0
      Triple nickle Triple nickle 3 months ago
      Ok bounce time 1.03
      👍️0
      tw0122 tw0122 4 months ago
      Let’s go nice flipper
      👍️0
      Monksdream Monksdream 4 months ago
      CDIO under $2
      👍️0
      north40000 north40000 4 months ago
      A new notice of allowance for a patent application, titled:

      Compositions And Methods For Detecting Predisposition To Cardiovascular Disease.
      👍️0
      rosemountbomber rosemountbomber 4 months ago
      There has to be some news that we are not privy to. Huge beat down
      👍️0
      Monksdream Monksdream 5 months ago
      CDIO under $2
      👍️0
      luckydude777 luckydude777 5 months ago
      As expected, Market Makers are loading up on cheap shares before the next run starts. Get 'em while they're cheap, laddies.
      👍️0
      luckydude777 luckydude777 5 months ago
      This could be a HUGE positive marketing move with this morning's news. EASY ACCESS to the test may make all the difference in the world to CDIO. Stay tuned folks ...!!!
      👍️0
      saigai saigai 5 months ago
      there is no other way to interpret the recent ..last 6 weeks of in play.....this is gonna be huge... its coming
      👍️0
      luckydude777 luckydude777 5 months ago
      If their brain/s are working right, they release a good PR, and as the whole world scrambles to pick up shares, they'll start selling their shares at much higher prices.

      Appears she is heading higher though, as you say.
      👍️0
      saigai saigai 5 months ago
      todays filing is good news.. they are getting ready to sell some shares but they could have done that at higher prices a bunch of weeks back.. we gonna pop and then monster
      👍️0
      luckydude777 luckydude777 6 months ago
      The dip of the dip of the DIP! Gollllyyyyyyyyyyyyyyyyyyyy ... they sure are trying to shake out the weak, feeble and creating frightattacks.

      This could be grounds for a CLASS-ACTION LAWSUIT on behalf of insiders having coronaries.
      👍️0
      Runners123 Runners123 6 months ago
      Buy the dip
      👍️0
      luckydude777 luckydude777 6 months ago
      VERY GOOD news! Company is NOT cash strapped!

      "The First Convertible Debenture has been fully repaid, and as of January 4, 2024, the Company’s obligation to issue and sell, and Yorkville’s obligation to purchase, the Second Convertible Debenture has been terminated. At the time of termination, there were no outstanding borrowings, advance notices or shares of Common Stock to be issued under the Securities Purchase Agreement. In addition, there were no fees due by the Company or Yorkville in connection with the termination of the Securities Purchase Agreement.
      👍️0
      luckydude777 luckydude777 6 months ago
      Yep - predictable as the ocean will be wet come sundown.
      👍️0
      luckydude777 luckydude777 6 months ago
      More like I wonder how LOW they'll puke it just to show us that they CAN?
      👍️0
      luckydude777 luckydude777 6 months ago
      Will be interesting to see what kind of upside we get today from the news a bit earlier.
      👍️0
      saigai saigai 6 months ago
      sorry about the post wrong board for sure
      👍️0
      saigai saigai 6 months ago
      building a small position in intc...good value a few bucks i wont have to baby sit
      👍️0
      luckydude777 luckydude777 6 months ago
      I'm in agreement.
      👍️0
      saigai saigai 6 months ago
      it was a great trade on news day for many.. i can only hold.. the real buyers of this news added value will join us before weeks end ..
      👍️0
      saigai saigai 6 months ago
      still moves on a whisper. no dillution yet.. they have had a 100 different opps to sell into strength and they have not..they will offering in double digits or if they are really lucky get some big boy debt financing based on orders. revenue monster..imo
      👍️0
      Whalatane Whalatane 6 months ago
      This is just my opinion as a secondary prevention coronary heart disease patient with a family history of early heart attacks.
      Their test is a risk calculator ...not IMHO a diagnostic test.
      Diagnostic tests are done if you are in the ER with chest pains and they are doing Tropin tests , EKG readings etc and deciding weither or not to send you to the Cath lab for an angiogram.
      CDIO's test is a combination of a DNA test and a lipid panel ....if I have that wrong , please correct.

      Have you checked how much cash on hand they have ...chk the latest 10Q...because if they are low on COH ( which they probably are ) they are likely to use this news event to raise cash
      Last 10Q they had $4.5m in cash , prepaid expenses etc and were running close to $2m in loss's each Qt
      They may have had a cash infusion since that report

      Kiwi
      👍️0
      luckydude777 luckydude777 6 months ago
      They can always drop the $350 price of the test. And/or ... insurance companies may come to believe that $350 for the test is MUCH CHEAPER than all the extensive/EXPENSIVE testing for heart conditions the way it is currently being done.
      👍️0
      Whalatane Whalatane 6 months ago
      CHICAGO, January 02, 2024--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural Terminology (CPT®) Proprietary Laboratory Analysis (PLA), 0440U, for the company’s AI-driven coronary heart disease (CHD) detection test, PrecisionCHD. Receipt of this new CPT PLA code, which will be effective on April 1, 2024, is a significant step toward payer billing and payment, facilitating broader adoption of the first and only integrated genetic-epigenetic diagnostic blood test for CHD.


      Congrats on the move.
      Doubt if payers or patients will pay the $350 ? the Co wants for this test ...but so far the mkt's buying the hype
      No position
      Good luck
      Kiwi
      👍️0
      Whalatane Whalatane 6 months ago
      North. Happy New Year . Are U still in CDIO and do you have any explanation on current stock movements ...short covering or an actual fundamental story playing out ?
      Congrats if you are still in this .
      No position
      Kiwi
      👍️0
      Bud-Wiser Bud-Wiser 6 months ago
      Sold half of mine @2.65 weeks ago .. she did go all the way back down to like 1.25 and I felt good about it then …but now I’m not feeling so great
      👍️0
      luckydude777 luckydude777 6 months ago
      Now that coding will be set in place (April), the company can NOW release news about OTHER medical facilities who plan to use the test ... or are already administering it.
      👍️0
      1hot toddy 1hot toddy 7 months ago
      too bad u didnt buy when it was 32 cents $$$$$$$$$$
      👍️0
      UNDAUNTED UNDAUNTED 7 months ago
      Sold my stake at 2.36 (at 32 cent loss) but buying back as it drops to lower my avg
      👍️0
      luckydude777 luckydude777 7 months ago
      So it could get shorted back to near $2.00 per A/H.
      👍️0
      UNDAUNTED UNDAUNTED 7 months ago
      So anyone know why this shot up 40% in the last 5 min of trading Friday?
      👍️0
      S3lfMade S3lfMade 7 months ago
      R/S vote today!?
      👍️0
      luckydude777 luckydude777 7 months ago
      Back into CDIO at $2.17. This is where I STICKING for the next several weeks.
      👍️0
      conix conix 7 months ago
      CDIO will be fine come January. Biotech investors are looking forward to more biotech conferences in the new year.
      👍️0
      UNDAUNTED UNDAUNTED 7 months ago
      I'm still holding but you're in a better position than me. I won't even break even until it hits 2.65.
      👍️0
      Acehole Acehole 7 months ago
      Same here. I made a very nice chunk of money selling at 1.83 but damn did I feel stupid when it rocketed up to 2.30 shortly after. Always happens that way.
      👍️0
      UNDAUNTED UNDAUNTED 7 months ago
      So no one knows why this shot up 5 minutes before closing bell?
      👍️0
      luckydude777 luckydude777 7 months ago
      With HUBC ... I feel that is a pretty MEATY PR they released this morning. Of the same caliber of news when CDIO got FDA approval of their testing.

      I know this may be stretching things a bit, but my gut feeling is that the government may get behind HUBC behind closed doors. Should that happen down the road, I see HUBC becoming a big-boy stock much more than CDIO, but what the hey do I know???

      I DON'T think a person can go wrong holding CDIO shares, that's for SURE. I just don't have enough available cash at the present to hold shares in both companies to make it worth my while sitting in BOTH companies -- at the present anyway.
      👍️0
      saigai saigai 7 months ago
      hubc ill give a look.. i have some powder for monday thanks
      👍️0
      luckydude777 luckydude777 7 months ago
      Noooooooooooooooo ... it went up because I dumped all my CDIO shares earlier before the liftoff and put the proceeds into HUBC. ALWAYS happens that way when I sell a good stock more than not.

      I think CDIO has so much potential, but I also think HUBC can have MORE ... depending how things play out. We'll see ...
      👍️0

      Your Recent History

      NASDAQ
      CDIO
      Cardio Diagnostics
      Delayed Upgrade Clock